Pharma & Biotech

Eli Lilly has become the first pharmaceutical company globally to surpass a $1 trillion market valuation, marking an unprecedented milestone...

BioNxt Solutions has secured a significant intellectual property milestone with the formal grant of a patent from the Eurasian Patent...

Amphastar Pharmaceuticals witnessed a significant uptick in its stock performance after releasing quarterly results that substantially outpaced market projections. The...

The Danish pharmaceutical powerhouse, once celebrated for its groundbreaking weight-loss treatment Wegovy, is confronting a severe market downturn. A combination...

Shareholders of the Tübingen-based biotech firm CureVac are approaching a decisive moment. An extraordinary general meeting scheduled for Tuesday, November...

After losing nearly 60 percent of its value since reaching all-time highs, Redcare Pharmacy shares are navigating turbulent waters, closing...

Despite securing intellectual property rights that unlock access to a vast market of more than 200 million people, Bionxt Solutions...

The equity story for Hims & Hers is currently defined by a dramatic clash between persistent market anxieties and emerging...

Eli Lilly has achieved a monumental financial milestone, becoming the first pharmaceutical company ever to surpass a $1 trillion market...

Monopar Therapeutics Inc. (MNPR) experienced a dramatic upward move during Friday's trading, with its shares posting a substantial gain exceeding...